LDR | |
01350nam a22003611a 4500 |
001 |
|
001825809 |
003 |
|
MiAaHDL |
005 |
|
20221205000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
900205s19899999nyua b 10100 eng c |
010 |
⊔ |
⊔ |
‡a89016926
|
020 |
⊔ |
⊔ |
‡a0444015094
‡q(alk. paper)
|
035 |
⊔ |
⊔ |
‡a(MiU)990018258090106381
|
035 |
⊔ |
⊔ |
‡asdr-miu.990018258090106381
|
035 |
⊔ |
⊔ |
‡z(MiU)MIU01000000000000001825809-goog
|
035 |
⊔ |
⊔ |
‡a(OCoLC)20056838
|
035 |
⊔ |
⊔ |
‡a(RLIN)MIUG90-B4524
|
035 |
⊔ |
⊔ |
‡z(MiU)Aleph001825809
|
040 |
⊔ |
⊔ |
‡aDNLM/DLC
‡cDLC
|
050 |
1 |
⊔ |
‡aRC114.5
‡b.A555 1989
|
060 |
⊔ |
⊔ |
‡aWC 500 A6335 1988
|
082 |
0 |
⊔ |
‡a616.9/25061
‡220
|
245 |
0 |
0 |
‡aAntiviral chemotherapy :
‡bnew directions for clinical application and research /
‡ceditors, John Mills, Lawrence Corey.
|
260 |
⊔ |
⊔ |
‡aNew York :
‡bElsevier,
‡cc1989
|
300 |
⊔ |
⊔ |
‡av. ;
‡c24 cm.
|
500 |
⊔ |
⊔ |
‡aEdited proceedings of a conference held in San Francisco, Nov. 3-5, 1988.
|
504 |
⊔ |
⊔ |
‡aIncludes bibliographical references.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
2 |
‡aVirus Diseases
‡xdrug therapy
‡xcongresses.
|
650 |
⊔ |
2 |
‡aAntiviral Agents
‡xtherapeutic use
‡xcongresses.
|
650 |
⊔ |
0 |
‡aAntiviral agents
‡vCongresses.
|
650 |
⊔ |
0 |
‡aRetrovirus infections
‡xChemotherapy
‡xCongresses.
|
650 |
⊔ |
0 |
‡aVirus diseases
‡xChemotherapy
‡xCongresses.
|
700 |
1 |
⊔ |
‡aCorey, Lawrence.
|
700 |
1 |
⊔ |
‡aMills, John,
‡d1940-
|
899 |
⊔ |
⊔ |
‡a39015015449757
|
CID |
⊔ |
⊔ |
‡a001825809
|
DAT |
0 |
⊔ |
‡a19931021000000.0
‡b20221205000000.0
|
DAT |
1 |
⊔ |
‡a20221207060734.0
‡b2023-06-24T17:44:50Z
|
CAT |
⊔ |
⊔ |
‡aSDR-MIU
‡cmiu
‡dALMA
‡lprepare.pl-004-008
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-miu.990018258090106381
‡aMiU
‡bSDR
‡cMIU
‡f001825809
‡pmdp.39015015449757
‡sMIU
‡1990018258090106381
|
974 |
⊔ |
⊔ |
‡bMIU
‡cMIU
‡d20230624
‡sgoogle
‡umdp.39015015449757
‡ric
‡qbib
‡tUS bib date2 >= 1929
|